Modern concepts of cancer immunology originated from the classicobservations by Jensen, Loeb, Tyzzer, and Little in the earlyyears of the 20th century of the rejection of transplanted allogeneictumors and the acceptance of syngeneic tumors.1 Despite thislaw of transplantation, there are several clinical examplesof the accidental transplantation of a malignant tumor or tumorcells into a healthy recipient.2,3,4,5
We describe the accidental transplantation of a malignant sarcomafrom a patient to a surgeon. Using molecular methods, we showedthat the sarcomas in the unrelated patient and surgeon weregenetically identical.
Case Report
A 32-year-old man underwent emergency surgery to remove a malignantfibrous histiocytoma from his abdomen and died shortly thereafterof postoperative complications. During the operation the 53-year-oldsurgeon injured the palm of his left hand while placing a drain.The lesion was immediately disinfected and dressed. Five monthslater, the surgeon consulted a hand specialist because of ahard, circumscribed, tumor-like swelling, 3.0 cm (1.2 in.) indiameter, in his left palm at the base of the middle finger,where he had been injured during the operation. An extensiveexamination, including laboratory tests, did not reveal anysigns of immune deficiency. The tumor was completely excised.Histologic examination revealed that it was a malignant fibroushistiocytoma. Two years later, the surgeon's condition was good,and there was no evidence of recurrence or metastasis of thetumor.
The pathologist who investigated both the patient's tumor andthe surgeon's tumor raised the question whether the tumors wereidentical.
Methods
Histologic and Immunohistologic Analysis
Samples of tumor tissue from the patient and surgeon were embeddedin paraffin and stained with hematoxylin and eosin, periodicacidSchiff, and van Gieson's stain. Immunostaining wasperformed with the avidinbiotinperoxidase method,with antibodies against vimentin, lysozyme, alpha1-antitrypsin,alpha1-antichymotrypsin, keratin, endomysial antigens, S100,actin, and desmin (all antibodies were obtained from Dako, Glestrup,Denmark).
Isolation of DNA
Genomic DNA from peripheral-blood samples was isolated by the"salting-out" method.6 DNA from paraffin-embedded tumor andtissue samples was extracted according to a modification7 ofthe method of Goelz et al.8
Analysis of Short Tandem-Repeat Polymorphisms
Short tandem-repeat polymorphisms of the loci HUMTH01, HUMCYAR04,and HUMACTBP2 were amplified by the polymerase chain reaction(PCR) with fluorescence-labeled primers. Primer sequences werechosen from published sequences.9,10,11 The 5' primer for HUMCYAR04was labeled with 5-carboxylfluorescein, whereas the 5' primersfor HUMTH01 and HUMACTBP2 were labeled with 6-carboxy-2',4',7',4,7-hexachlorofluorescein.PCR products were analyzed with an automated DNA sequencer (model373A, Applied Biosystem Division, Perkin-Elmer, Foster City,Calif.).
Sequence-Based Typing of HLA Genes
Typing of HLA-DRB1 and DQB1 alleles was performed by allele-specificPCR amplification in combination with solid-phase direct DNAsequencing. Sequence analysis was performed on an automatedDNA sequencer (model 373A, Perkin-Elmer). Primer sequences werechosen from genomic sequences of HLA-DRB1 and DQB112 or frompublished sequences.13
Results
Histologic analysis of tumor tissues from the surgeon and thepatient revealed that they were morphologically identical. Bothtumors were malignant fibrous histiocytomas of the storiformpleomorphicsubtype (Figure 1A). They consisted mainly of fibroblast-likeand histiocyte-like cells, arranged in a fascicular and storiformpattern, intermingled with some pleomorphic cells and a fewinflammatory cells. There were numerous mitotic figures andmany necrotic areas. In the periphery of the surgeon's tumor,there was intense inflammation, with an infiltrate consistingmainly of lymphocytes and macrophages and few plasma cells (Figure 1B).Both tumors stained for vimentin, alpha1-antitrypsin, andalpha1-antichymotrypsin.
Figure 1. Histologic Findings (Panels A and B) and Immunologic Findings (Panel C) on Analysis of the Patient's and the Surgeon's Tumors.
Both the patient's tumor (Panel A; van Gieson's stain, x20) and the surgeon's tumor (Panel B; hematoxylin and eosin, x20) were malignant fibrous histiocytomas. The surgeon's tumor was surrounded by an inflammatory process, with dense infiltrates, consisting mainly of lymphocytes and macrophages. Panel C shows electrophoretograms of short tandem-repeat sequences of loci HUMACTBP2, HUMTH01, and HUMCYAR04. Peaks represent fluorescence intensities of dye-labeled DNA products.
Analysis of short tandem-repeat sequences clearly demonstrateda chimeric constellation of alleles in the surgeon's tumor (Figure 1C).Allele 11 (187 bp) of HUMCYAR04, allele 8 (166 bp) of HUMTH01,and allele 31 (300 bp) of HUMACTBP2 were detected in the tumorsfrom both the patient and the surgeon (Table 1). To rule outa tumor-specific genetic pattern of these short tandem-repeatpolymorphisms, a DNA sample from another malignant fibrous histiocytoma,histologically identical to the tumors of the patient and thesurgeon, was analyzed. The allelic profile of this control malignantfibrous histiocytoma, identified by analysis of short tandem-repeatsequences, was clearly distinct from that of the patient's andthe surgeon's tumors (Table 1).
Table 1. Results of Analysis of Polymorphic Short Tandem-Repeat Sequences and HLA Analysis.
Sequence analysis of HLA-DRB1 and DQB1 genes revealed a constellationof heterozygous alleles in the patient's tumor and in the peripheralblood of the surgeon (Table 1). All four alleles, two from thepatient's tumor and two from the surgeon's blood cells, werepresent in the tumor sample from the surgeon.
Discussion
We used histologic and immunohistologic methods, analysis ofshort tandem-repeat polymorphisms, and sequence-based typingof HLA genes to determine the genetic origin of a sarcoma thathad been accidentally transplanted from a patient to a surgeon.Both the pattern of short tandem-repeat sequences and the chimericconstellation of HLA alleles in the surgeon's tumor identifiedthe genetic origin of the sarcoma. The patient and the surgeonhad different HLA haplotypes, with complete discrepancies ofDRB1 and DQB1 alleles. The patient died before we could performHLA class I typing, but from the linkage disequilibrium betweenHLA genes we can assume that there were also major class I mismatchesbetween the patient and the surgeon.
Normally, transplantation of allogeneic tissue from one personto another induces an immune response that leads to the rejectionof the transplanted tissue.1,14,15,16,17 In the case of thesurgeon, an intense inflammatory reaction developed in the tissuesurrounding the tumor, but the tumor mass increased, suggestingan ineffective antitumor immune response. The tumor may haveescaped immunologic destruction through several mechanisms,such as qualitative and quantitative changes of major histocompatibilitycomplex class I molecules on the tumor cells, an absence ofimmunogenic tumor antigens,18,19,20,21,22 deficient antigenprocessing by the tumor, or deficient presentation of tumorantigens by the host's antigen-presenting cells in the absenceof costimulatory signals with consequent T-cell and B-cell anergy.23,24,25
We are indebted to Dr. Hans Georg Rammensee for his criticalreview of the manuscript and to Utz Bacher for his excellentsecretarial assistance.
Source Information
From the Institutes of Pathology (H.-V.G., B.B.) and Anthropology and Human Genetics (C.L., H.R.), Eberhard-Karls-Universität, Tübingen; the Institute of Transfusion Medicine and Immunohematology, Red Cross Blood Donor Service, Frankfurt am Main (C.S., E.S.); and the Institute of Pathology, General Hospital, Heilbronn (G.S.) all in Germany.
Address reprint requests to Dr. Gärtner at the Institute of Pathology, Eberhard-Karls-Universität, Liebermeisterstraße 8, D-72076 Tübingen, Germany.
References
Klein J. Natural history of the major histocompatibility complex. New York: John Wiley, 1986.
Southam CM. Homotransplantation of human cell lines. Bull N Y Acad Med 1958;34:416-423. [Medline]
Nadler SH, Moore GE. Immunotherapy of malignant disease. Arch Surg 1969;99:376-381. [Free Full Text]
Scanlon EF, Hawkins RA, Fox WW, Smith WS. Fatal homotransplanted melanoma: a case report. Cancer 1965;18:782-789. [CrossRef][Medline]
Gugel EA, Sanders ME. Needle-stick transmission of human colonic adenocarcinoma. N Engl J Med 1986;315:1487-1487. [Medline]
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215-1218. [Free Full Text]
Luckenbach C, Gärtner HV, Seidl C, Ritter H. Tumor inoculation between two unrelated human individuals: STR analysis of paraffin-embedded tissue section. Adv Forensic Haemogenet 1996;6:192-4.
Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985;130:118-126. [CrossRef][Medline]
Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). Nucleic Acids Res 1991;19:3753-3753. [Free Full Text]
Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res 1991;19:195-195. [Free Full Text]
Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human beta-actin related pseudogene H-beta-Ac-psi-2 (ACTBP2). Nucleic Acids Res 1992;20:1432-1432. [Free Full Text]
Marsh SGE, Bodmer JG. HLA class II nucleotide sequences, 1992. Tissue Antigens 1992;40:229-243. [Medline]
Bein G, Gläser R, Kirchner H. Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens 1992;39:68-73. [Medline]
Boon T. Toward a genetic analysis of tumor rejection antigens. Adv Cancer Res 1992;58:177-210. [Medline]
Moller P, Hammerling GJ. The role of surface HLA-A,B,C molecules in tumor immunity. Cancer Surv 1992;13:101-127. [Medline]
Schreiber H. Tumor immunology. In: Paul WE, ed. Fundamental immunology. 3rd ed. New York: Raven Press, 1993:1143-78.
Colonna M. Natural killer cell receptors specific for MHC class I molecules. Curr Opin Immunol 1996;8:101-107. [CrossRef][Medline]
Goodenow RS, Vogel JM, Linsk RL. Histocompatibility antigens on murine tumors. Science 1985;230:777-783. [Free Full Text]
Tanaka K, Yoshioka T, Bieberich C, Jay G. Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. Annu Rev Immunol 1988;6:359-380. [CrossRef][Medline]
Ljunggren HG, Kärre K. In search of the `missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244. [CrossRef][Medline]
Travers PJ, Arklie JL, Trowsdale J, Patillo RA, Bodmer WF. Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines. In: Greenwald P, ed. Research frontiers in aging and cancer: international symposium for the 1980's. NCI monograph 60. Washington, D.C.: Government Printing Office, 1982:175-80. (NIH publication no. 82-2436).
Rammensee HG, Fischer Lindhal K. Less scholasticism, more exact immunology. Curr Opin Immunol 1996;8:49-50. [CrossRef][Medline]
Suthanthiran M. Transmembrane signaling requirements of T-cells: implications for regulation of alloimmunity. Transplant Proc 1995;27:Suppl 1:5-7.
Boussiotis VA, Gribben JG, Freeman GJ, Nadler LM. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr Opin Immunol 1994;6:797-807. [CrossRef][Medline]
McHugh RS, Ahmed SN, Wang YC, Sell KW, Selvaraj P. Construction, purification and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80). Proc Natl Acad Sci U S A 1995;92:8059-8063. [Free Full Text]
Kobayashi, N., Fujiwara, T., Westerman, K. A., Inoue, Y., Sakaguchi, M., Noguchi, H., Miyazaki, M., Cai, J., Tanaka, N., Fox, I. J., Leboulch, P.
(2000). Prevention of Acute Liver Failure in Rats with Reversibly Immortalized Human Hepatocytes. Science
287: 1258-1262
[Abstract][Full Text]
Gazdar, A. F.
(1997). Tumors Arising After Organ Transplantation: Sorting Out Their Origins. JAMA
277: 154-155
[Abstract]